EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD

被引：0
|
作者：
Abdullaev, Sherzod [1 ]
Sharapov, Olimkhon [2 ]
机构：
[1] Republican Sci & Pract Med Ctr Nephrol & Kidney T, Immunogenet, Tashkent, Uzbekistan
[2] Republican Sci & Pract Med Ctr Nephrol & Kidney T, Adult & Pediat Nephrol, Tashkent, Uzbekistan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
3015
引用
收藏
页码：I685 / I686
页数：2
相关论文
共 50 条
  • [1] Effect of dapagliflozin on renal and cardiac function in patients with type 2 diabetes and albuminuria: a randomised study
    Eickhoff, M. K.
    Olsen, F. J.
    Frimodt-Moller, M.
    Diaz, L. J.
    Jensen, M. T.
    Rossing, P.
    Persson, F.
    [J]. DIABETOLOGIA, 2018, 61 : S299 - S300
  • [2] Dapagliflozin Efficacy Is Unaffected by Baseline Albuminuria Level in Patients with Type 2 Diabetes
    Parikh, Shamik J.
    Lacreta, Frank
    Liu, Xiaoni
    Sugg, Jennifer E.
    Boulton, David W.
    [J]. DIABETES, 2015, 64 : A29 - A29
  • [3] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [4] DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL
    Jong, Niels
    Chertow, Glenn
    Hou, Fan Fan
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur
    Toto, Robert
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo Lambers
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [5] Effect of Dapagliflozin on Soluble Urokinase-Type Plasminogen Activator Receptor in Type 2 Diabetes with Albuminuria
    Curovic, Viktor Rotbain
    Eickhoff, Mie K.
    Houlind, Morten B.
    Frimodt-Moller, Marie
    Hansen, Tine
    Eugen-Olsen, Jesper
    Rossing, Peter
    Persson, Frederik
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 275 - 275
  • [6] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Fioretto, Paola
    Stefansson, Bergur V.
    Johnsson, Eva
    Cain, Valerie A.
    Sjostrom, C. David
    [J]. DIABETOLOGIA, 2016, 59 (09) : 2036 - 2039
  • [7] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Paola Fioretto
    Bergur V. Stefansson
    Eva Johnsson
    Valerie A. Cain
    C. David Sjöström
    [J]. Diabetologia, 2016, 59 : 2036 - 2039
  • [8] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [9] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
  • [10] Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes
    Bletsa, Evdoxia
    Filippas-Dekouan, Sebastien
    Kostara, Christina
    Dafopoulos, Panagiotis
    Dimou, Aikaterini
    Pappa, Eleni
    Chasapi, Styliani
    Spyroulias, Georgios
    Koutsovasilis, Anastasios
    Bairaktari, Eleni
    Ferrannini, Ele
    Tsimihodimos, Vasilis
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05): : 1269 - 1283
12345